Free radicals and low-level photon emission in human pathogenesis: State of the art

Indian Journal of Experimental Biology

Volumn 46, Issue 5, 2008, Pages 273-309

  Van Wijk, Roeland ^a   Van Wijk, Eduard P A ^a   Wiegant, Fred A C ^b   Ives, John ^c  

^a International Institute of Biophysics   (Germany)

^b UTRECHT UNIVERSITY   (Netherlands)

^c SAMUELI INSTITUTE   (United States)

Author keywords

Antioxidants; Chaperones; Chronic disease; Free radicals; Heat shock proteins; Photon count distribution; Ultraweak photon emission

Indexed keywords

ANTIOXIDANT; CHAPERONE; FREE RADICAL; HEAT SHOCK PROTEIN; HYDROGEN PEROXIDE; OXYGEN; REACTIVE OXYGEN METABOLITE;

BIOPHYSICS; CHEMISTRY; GENE EXPRESSION REGULATION; HEAT; HUMAN; METABOLISM; METHODOLOGY; NEOPLASM; OXIDATIVE STRESS; PHOTON; REPERFUSION INJURY; REVIEW;

ANTIOXIDANTS; BIOPHYSICS; FREE RADICALS; GENE EXPRESSION REGULATION; HEAT; HEAT-SHOCK PROTEINS; HUMANS; HYDROGEN PEROXIDE; MOLECULAR CHAPERONES; NEOPLASMS; OXIDATIVE STRESS; OXYGEN; PHOTONS; REACTIVE OXYGEN SPECIES; REPERFUSION INJURY;

EID: 50649099701     PISSN: 00195189     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (442)

1. Gerschman R, Historical introduction to the "free radical theory" of oxygen toxicity, in: Oxygen and living processes, an interdisciplinary approach, edited by DL Gilbert (Springer, New York, USA) 1981, 44.
2. Harman D. Aging, a theory based on free radical and radiation chemistry, J.Geronto, 11 (1956) 298.
3. McCord J M & Fridovich I, Superoxide dismutase. An enzymic function for erythrocuprein (hemocuprein), J Biol Chem, 224 (1969) 6049.
4. Freeman B A & Crapo J D, Biology of disease: free radicals and tissue injury, Lab Invest, 47 (1982) 412.
5. Pryor W A, Free radical biology: xenobiotics, cancer and aging, Ann NY Acad Sci, 393 (1982) 1.
6. Sies H, Oxidative stress (Academic Press, New York, USA) 1985.
7. Cross D E B, Halliwell E T, Borish W A, Pryor B A, Ames R S, Saul J M, McCord & Harman D, Oxygen radicals and human disease, Ann Intern Med, 107 (1987) 526.
8. Koster J F, Biemand P & Stam H, Lipid peroxidation and myocardial ischaemic damage: cause or consequence? in Lipid metabolism in the normoxic and alchemic heart, edited by H Stam H, G J Vusse (Steinkhoff Verlag, Darmstadt) 1986, 253.
9. Cerutti P A, Fridovich I & McCord J M, Oxy-radicals in molecular and cellular biology, in New Series 82, edited by R Alan (Liss Inc, New York) 1988.
10. Dormandi T L, Free radical pathology and medicine: a review, J R Coll Physic (London), 23 (1989) 221.
11. Poli G, Cheeseman K H, Dianzani M U & Slater T F, Free radicals in the pathogenesis of liver injury (Pergamon Press, Oxford) 1989.
12. Packer L, Glazer, Methods in enzymology: oxygen radicals in biological systems, Part B: Oxygen radicals and antioxidants, (Academic Press, New York, NY), Vol.186, 1990.
13. Dargel R, Lipid peroxidation - a common pathogenetic mechanism? Exp. Toxic. Pathol, 44 (1992) 169.
14. McElroy W D & Seliger H H, Origin and evolution of bioluminescence, in Horizons in biochemistry, edited by M Kasha and B Pullman (Academic Press, New York) 1962, 91.
15. McElroy W D & Seliger H H, The chemistry of light emission, Adv Enzymol Relat Areas Mol Biol, 25 (1963) 119.
16. Seliger H H, The origin of bioluminescence, Photochem.Photobiol,21 (1975) 355.
17. Tarusov B N, Polidova A I & Zhuravlev A I, Study on ultraweak spontaneous luminescence of animal cells, Biofizika, 6 (1961) 490.
18. Tarusov B N, Polidova N A I, Zhuralev A I, & Sekamova E N, Ultraweak spontaneous luminescence in animal tissue, Tsitologiya, 4 (1962) 696.
19. Baremboim G M, Domannski A N & Taroverov K K, Luminescence of biopolymers and cells (Plenum, New York) 1969.
20. Stauff J & Ostrowski J, Chemoluminescence of mitochondria, Z. Naturforsch B, 22 (1967) 743.
21. Howes R M & Steele R H, Microsomal ( S) chemiluminescence (CL) induced by NADPH and its relation to lipid peroxidation, Res. Commun. Chem. Pathol. Pharmacol, 2 (1971) 619.
22. Howes R M & Steele R H, Microsomal (muS) chemiluminescence (CL) induced by NADPH and its relation to aryl-hydroxylations, Res. Commun. Chem. Pathol. Pharmacol, 3 (1972) 349.
23. Gurwitsch A A, Eremeyev V F & Karabchievsky Y A, Ultraweak emission in the visible and ultra-violet regions in oxidation of solutions of glycine by hydrogen peroxide, Nature, 3 (1965) 206.
24. Gurvitsch A G & Gurvitsch L D, Die Mitogenitsche Strahlung (Fischer, Jena) 1959.
25. Metcalf W S & Quickenden T I, Mitogenetic radiation, Nature, 216(5111) (1967) 169.
26. Halliwell B & Gutteridge J M C, The importance of free radicals and catalytic metal ions in human disease, Mol asp Med, 8 (1985) 89.
27. Forman H J & Boveris A, Superoxide radical and hydrogen peroxide in mitochondria, in Free radicals in biology (Academic Press, Inc., New York) 1982, 65.
28. Chance B, Sies H & Boveris A, Hydroperoxide metabolism in mammalian organs, Physiol Rev, 59 (1979) 527.
29. Kellogg E W & Fridovich I, Superoxide, hydrogen peroxide, and singlet oxygen in lipid peroxidation by a xanthine oxidase system, J Biol Chem, 250 (1975) 8812.
30. McCord J M, Oxygen-derived free radicals in postischemic tissue injury, N Engl J Med, 312 (1985) 159.
31. Halliwell B & Gutteridge J M, The importance of free radicals and catalytic metal ions in human diseases, Mol Aspects Med, 8 (1985) 89.
32. Haber F & Weiss J, The catalytic decomposition of hydrogen peroxide by iron salts, Proc R Soc London A, (1934) 332.
33. Wilson R B, Middleton C C & Sun G Y, Vitamin E, antioxidants and lipid peroxidation in experimental atherosclerosis of rabbits, J Nutr, 108 (1978) 1858.
34. Del Río L A, Sandalio L M, Palma J M, Bueno P & Corpas F J, Metabolism of oxygen radicals in peroxisomes and cellular implications, Free Radic Biol Med, 13 (1992) 557.
35. Gebicki S, Gill K H, Dean R T & Gebicki J M, Action of peroxidases on protein hydroperoxides, Redox Rep, 7 (2002) 235.
36. Autor A P, Pathology of oxygen, (Acedemic Press, New York) 1982.
37. Sies H, Strategies of antioxidant defense, Eur J Biochem, 215 (1993) 213
38. Rose R & Bode A, Biology of free radical scavengers, FASEB Journal, 7 (1993) 1135.
39. Goto Y, Lipid peroxides as a cause of vascular disease. Lipid peroxides in biology and medicine, (Academic Press, New York) 1982, 295.
40. Taylor A.E., Matalon S & Ward P.A, Psysiology of oxygen radicals (Americ Physiol Society, Bethesda) 1986.
41. DeGroot H & Littauer A, Hypoxia, reactive oxygen and cell injury, Free Radical Biol Med, 6 (1989) 541.
42. Braughler J M & Hall E D, Central nervous system trauma and stroke: I. Biochemical considerations for oxygen radical formation and lipid peroxidation, Free Radic Biol Med, 6 (1989) 289.
43. Hall E D & Braughler J M, Central nervous system trauma and stroke. II. Physiological and pharmacological evidence for involvement of oxygen radicals and lipid peroxidation, Free Radic Biol Med, 9 (1989) 303.
44. Van der Kraaij A M, Schoonderwood K & Koster J F et al., Lipid peroxidation and its significance for (post) ischemic cardiovascular injury, Prog Clin Biol Res, 301 (1989) 61.
45. Gores G J, Flrsheim C E, Dawson T L, Nieminen A-L, Herman B & Lemasters J J, Swelling, reductive stress, and cell death in hepatocytes, Am. J. Physiol. 257, (Cell Physiol 26) (1989) C347.
46. Gores G J, Nieminen A-L, Fleishman K E, Dawson T L, Herman B & Lemasters J J, Extracellular a idosis delays the onset of cell death in ATP-depleted hepatocytes, Am. J. Physiol 255, (Cell Physiol 24) (1988) C315.
47. Gores, G K, Nieminen A-L, Wray B E, Herman B & Lemasters J J, Intracellular pH during "chemical hypoxia"in cultured rat hepatocytes by intracellular acidosis against theonset of cell death, J Clin Invest, 83 (1989) 386.
48. 2+ oscillations in cultured rat hepatocytes by chemical hypoxia, J Biol Chem, 266 (1991) 20062.
49. 2+ and mitochondrial membrane potential preceding celldeath in hepatocytes, Nature, 325 (1987) 78.
50. Dawson T L, Gores G J, Nieminen A-L, Herman B & Lemasters J J, Mitochondria as a source of reactive oxygen species during reductive stress in rat hepatocytes, Am J Physiol, 264 (1993) 961.
51. Cairns J A, Collins R, Fuster V & Paasamani E R, Coronary thrombolysis, Chest 95 (1989) 73S.
52. Starzl T E, Transplantation, JAMA, 261(19) (1989) 2894.
53. Jones D P, The role of oxygen concentration in oxidative stress: hypoxic and hyperoxic models. In: Oxidative Stress, edited by H. Sies (Academic Press, London) 1985, 152.
54. Maupoil V & Rochette L, Evaluation of free radical and lipid peroxide formation during global ischemia and reperfusion in isolated perfused rat heart. Cardiovasc, Drugs Ther, 2 (1988) 615.
55. Brown J M, Terada LS, Grosso M A, Whitmann G J, Velasco S E, Patt A, Harken A H & Repine J E, Xanthine oxidase produces hydrogen peroxide which contributes to reperfusion injury of ischemic, isolated, perfused rat hearts, J Clin Invest, 81 (1988) 1297.
56. Ferrari R, Cargnoni A, Curello S, Boffa G M & Ceconi C, Effects of iloprost (ZK 36374) on glutathione status during ischaemia and reperfusion of rabbit isolated hearts, Br J Pharmacol, 98 (1989) 678.
57. Cerutti, P A, Fridovich, I & McCord, J. M. Oxy-radicals in molecular biology and pathology (Alan R. Liss, New York) 1988.
58. Nauta R J, Tsimoyiannis E, Uribe M, Walsh D B, Miller D & Butterfield A, Oxygenderived free radicals in hepatic ischemia and reperfusion injury in the rat, Gynecol Obstet, 171 (1990) 120.
59. Taylor AE, Matalon S & Ward PA, Physiology of oxygen radicals (Williams and Wilkins, Baltimore) 1986.
60. Zweier J L, Flaherty J T & Weisefeldt ML, Direct measurement of free radical generation following reperfusion of ischemic myocardium, Proc Natl Acad Sci USA, 84 (1987) 1404.
61. Zweier J L, Rayburn B K, Flaherty JT & Weisfeldt M L, Recombinant superoxide dismutase reduces oxygen free radical concentrations in reperfused myocardium, J Clin Invest, 80 (1987) 1728.
62. Zweier J L, Measurement of superoxide-derived free radicals in the reperfused heart. Evidence for a free radical mechanism of reperfusion injury, J Biol Chem, 263 (1988) 1353.
63. Ambrosio G, Zweier J L, Jacobus W E, Weisfeldt M L & Flaherty J T, Improvement of postischemic myocardial function and metabolism induced by administration of deferoxamine at the time of reflow: the role of iron in the pathogenesis of reperfusion injury, Circulation 76, (1987) 906.
64. Blasig I E, Bor P, Tosaki A, Szekeres L & Löwe H, Effect of activated oxygen species on mitochondria isolated from myocardium after reperfusion injury, Gen Physiol Biophys, 5(6) (1986 Dec) 655.
65. Arroyo C M, Kramer J H, Dickens B F & Weglicki W B, Identification of free radicals in myocardial ischemia/reperfusion by spin trapping with nitrone DMPO, FEBS Lett, 221 (1987) 101.
66. Zweier J L, Kuppusamy P, Williams R, Rayburn B K, Smith D, Weisfeldt M L & Flaherty J T, Measurement and characterization of post ischemic free radical generation in the isolated perfused heart, J Biol Chem, 264 (1989) 18890.
67. Thompson-Gorman S L & Zweier J L, Evaluation of the role of xanthine oxidase in myocardial reperfusion injury, J Biol Chem, 265 (1990) 6656.
68. Grill H P, Flaherty J T, Zweier J L, Kuppusamy P & Weisfeldt M L, Direct measurement of myocardial free radical generation in an in vivo model: effects of postischemic reperfusion and treatment with human recombinant superoxide dismutase, J Am Coll Cardiol, 20 (1992) 1604.
69. Bolli, R, Post ischemic myocardial "stunning", in Pathogenesis. pathophysiology and clinical relevance, edited by D M Yellon & R B Jennings (Raven Press, New York) 1992.
70. Hearse D J, Reperfusion-induced injury: A possible role of oxidant stress and its manipulation, Cardiovasc Drugs Ther, 5 (1991) 225.
71. Halliwell B, Reactive oxygen species in living systems: Source, biochemistry and role in human disease, Am. J Med, 91 (3C) (1991) 13S.
72. Oberley L W & Buettner G R, Role of superoxide dismutase in cancer: a review, Cancer Research, 39 (1979) 1141.
73. Sato K, Ito K, Kohara H, Yamaguchi Y, Adachi K & Endo H, Negative regulation of catalase gene expression in hepatoma cells, Mol Cell Biol, 12 (1992) 2525.
74. Szatrowski T P & Nathan C F, Production of large amounts of hydrogen peroxide by human tumor cells, Cancer Res, 51 (1991) 794.
75. Ahmed S M. & Slater, T F, Recent, in Recent Advances in lipid peroxidation and tissue injury, edited by T F Slater & A Garner (Brunel University, Uxbridge, U.K) 1981, 177
76. Cheeseman, K H, Carbon tetrachloride metabolism and lipid peroxidation in rat liver microcosomes (Brunel University, Uxbridge, U.K.) 1982.
77. Burlokova E B, Bioantioxidants and synthetic inhibitors of radical processes, Russian Chemical Reviews, 44 (1975) 871.
78. Ugazio G., Gabriel L & Burdino E, Research on the lipid peroxidase inhibitors present in the cells of Yoshida ascites hepatoma, Boll Soc Ital Biol Sper, 44 (1968) 30.
79. 2+-induced lipid peroxidation and swelling in the mitochondria isolated from ascites tumor cells, Biochim Biohys Acta, 105 (1965) 368.
80. Dionisi D, Galeotti T, Terranove T & Azzi A, Superoxide radicals and hydrogen peroxide formation in mitochondria from normal and neoplastic tissues, Biochim Biophys Acta, 403 (1975) 292.
81. Schreck R, Rieber P & Baeuerle P A, Reactive oxygen intermediates as apparently widely used messengers in the activation of the NF-kappa B transcription factor and HIV-1, EMBO J, 10 (1991) 2247.
82. Crawford D, Zbinden I, Amstad P & Cerutti P, Oxidant stress induces the protooncogenes c-fos and c-myc in mouse epidermal cells, Oncogene, 3 (1988) 27.
83. Shibanuma M, Mashimo J, Mita A, Kuroki T & Nose K, Cloning from a mouse osteoblastic cell line of a set of transforming growth factor 1-regulated genes, one of which seems to encode a follistatin-related polypeptide, Eur J Biochem, 217 (1993) 13.
84. Jaruga P, Zastawny T H, Skokowski J, Dizdaroglu M & Olinski R, Oxidative DNA base damage and antioxidant enzyme activities in human lung cancer, FEBS Lett, 341 (1994) 59.
85. Slater T F, Biochemical Pathology in microtime, Panminerva Medica, 18 (1976) 381.
86. Harman D, The biologic clock: The mitochondria? J Amer Geriat Soc, 20 (1972) 145.
87. Miquel J & Fleming J, Theoretical and experimental support for an "oxygen radical-mitochondrial injury" hypothesis of cell aging, in Free radicals, ageing and degenerative diseases, edited by J E Johnson, R Walford, D Harman & J Miquel (Alan R. Liss, New York) 1986, 51.
88. Fleming J E, Miquel J, Cottrell S F, Yengoyan L S & Economos A C, Is cell aging caused by respirationdependent injury to the mitochondrial genome? Gerontology, 28(1) (1982) 44.
89. Stauber J L & Florence T M, Mechanism of toxicity of ionic copper and copper complexes to algae, Mar Biol, 94 (1987) 511.
90. Fleming J E, Miquel J & Bensch K G, Age dependent changes in mitochondria, Basic Life Sci, 35, (1985) 143.
91. Marcus D L, Ibrahim N G & L. Freedman L, Age-related decline in the biosynthesis of mitiochondrial inner membrane proteins, Exp Gerontol, 17 (1982) 333.
92. Totter J R, Spontaneous cancer and its possible relationship to oxygen metabolism, Proc Natl Acad Sci USA 77 (1980) 1763.
93. Cohen S M, Purtilo D T & Ellwein L B, Pivotal role of increased cell proliferation in human carcinogenesis, Mod Pathol, 4 (1991) 371.
94. Ames B N, Shigenaga M K & Gold L S, DNA lesions, inducible DNA repair, and cell division: three key factors in mutagenesis and carcinogenesis, Environ Health Perspect, Dec 101 Suppl 5 (1993) 35. Review
95. Ames B N, Profet M & Gold L S, Dietary Pesticides (99.99% All Natural), Proc Natl Acad Sci USA, 87 (1990) 7772.
96. Cerutti P A, Oxidant stress and carcinogenesis, Eur J Clin Invest, 21(1) (1991) 1.
97. Amstad P A, Krupitza G & Cerutti P A, Mechanism of c-fos induction by active oxygen, Cancer Res, 52 (1992) 3952.
98. Orrenius S, Burkitt M J, Kass G E, Dypbukt J M & Nicotera P, Calcium ions and oxidative cell injury, Ann Neurol, 32 (1992) S33.
99. Cerutti P A, Prooxidant states and tumor promotion, Science, 227 (1985) 375.
100. Jamieson D, Oxygen toxicity and reactive oxygen metabolites in mammals, Free Rad Biol Med, 7 (1989) 87.
101. Sun Y, Free radicals, antioxidant enzymes, and carcinogenesis, Free Rad Biol Med, 8, (1990) 583.
102. Troll W & Wiesner R., The role of oxygen radicals as a possible mechanism of tumor promotion, Annu Rev Pharmcol Toxicol, 25 (1985) 509.
103. Weitzman S A, & Stossel T P, Effects of oxygen scavengers and antioxidants on phagocyte-induced mutagenesis, J Immunol, 182 (1982) 2770.
104. Salim A S, The permissive role of oxygen-derived in the development of colonic cancer in the rat, Int J Cancer, (1993) 1031.
105. Salim A S, Oxygen-derived free-radical scavengers prolong survival in colonic cancer, Chemotherapy, 38 (1992) 127.
106. Salim A S, Oxygen-derived free -radical scavengers prolong survival in gastric cancer, Chemotherapy, 38 (1992) 135.
107. Salim A S, Removing oxygen-derived free radicals delays hepatic metastases and prolongs survival in colonic cancer, Oncology, 49 (1992) 58.
108. Stamle, J, Singel D J & Loscalz, J, Biochemistry of nitric oxide and its redox-activated forms, Science, 251 (1992) 1898.
109. Ischiropoulos H, Zhu L & Beckman J S, Peroxynitrite formation from macrophage-derived nitric oxide, Arch Biochem Biophys, 298 (1992) 446.
110. Shacter E, Beecham E J, Covey J M, Kohn K W & Potter M, Activated neutrophils induce prolonged DNA damage in neighboring cells, Carcinogenesis, 9 (1988) 2297.
111. Yamashina K, Miller B E & Heppner G H, Macrophagemediated induction of drug-resistant variants in a mouse mammary tumor cell line, Cancer Res, 46 (1986) 2396.
112. Yamauchi T et al., Globular adiponectin protected ob/ob mice from diabetes and apoE-deficient mice from atherosclerosis, J Biol Chem, 278 (2003) 2461.
113. Beasley R P, Hepatitis B virus. The major etiology of hepatocellular carcinoma, Cancer, 61 (1988) 1942.
114. Tabor E & Kobayashi K, Hepatitis C virus, a causative infectious agent of non-A, non-B hepatitis: prevalence and structure--summary of a conference on hepatitis C virus as a cause of hepatocellular carcinoma, J Natl Cancer Inst, 84 (1992) 86.
115. Yu M-W, You S-L, Chang, A-S, Lu S-N, Liaw Y-F & Chen C-J, Association between hepatitis C virus antibodies and hepatocellular carcinoma in Taiwan, Cancer Res, 51 (1991) 5621.
116. Chen M & Mott K, Progress in assessment of. morbidity due to Schistosoma mansoni infection, Trop Diss Bull, 85 (1988) 2.
117. Chen M & Mott K, Progress in assessment of morbidity due to Schistosoma haematobium infection. A review of recent literature, Trop Dis Bull, 86 (1989) 1.
118. Sobala G M, Pignatelli B, Schorah C J, Bartsch H, Sanderson M, Dixon M F, Shires S, King R F G & Axon A T R, Levels of nitrite, nitrate, N-nitroso compounds, ascorbic acid and total bile acids in gastric juice of patients with and without precancerous conditions of the stomach, Carcinogenesis, 12 (1991) 193.
119. Kneller R W, Guo W-D, Hsing A W, Chen J-S, Blot W J, Li J-Y, Forman D & Fraumeni Jr. F J, Risk factors for stomach cancer in sixty-five Chinese counties, Cancer Epidemiol Biomarkers Prev, 1(2) (1992) 113.
120. Parsonnet J, Friedman G D, Vandersteen D P, Chang Y, Vogelman J H, Orentreich N & Sibley R K, Helicobacter pylori infection and the risk of gastric carcinoma, N Engl J Med, 325 (1991) 1127.
121. Dooley C P, Cohen H, Fitzgibbons P L, Bauer M, Appleman M D, Perez-Perez G I & Blaser, M J, Prevalence of Helicobacter pylori infection and histologic gastritis in asymptomatic persons, N Engl J Med, 321 (1989) 1562.
122. Cover T L & Blaser M J, Helicobacter pylori and gastroduodenal disease, Annu Rev Med, 43 (1992) 135.
123. The Eurogast Study Group An international association between Helicobacter pylori infection and gastric cancer, Lancet, 341 (1993) 1359.
124. Marsh J P & Mossman B T, Role of asbestos and active oxygen species in activation and expression of ornithine decarboxylase in hamster tracheal epithelial cells, Cancer Res, 51 (1991) 167.
125. Korkina L G, Durnev A D, Suslova T B, Cheremisina ZP, Daugel-Dauge N O & Afanas'ev I B, Oxygen radicalmediated mutagenic effect of asbestos on human lymphocytes: suppression by oxygen radical scavengers, Mutat Res, 265 (1992) 245.
126. Bankson D D, Kestin M & Rifia N, Role of free radicals in cancer and artheroclerosis, Clin Lab Med, 13 (1993) 463.
127. Halliwell B, The role of oxygen radicals in human disease, Haemostasis, 23 (suppl) (1993) S118.
128. Lankin V Z, Vikhert A M, Tikhaze A K, et al., The role of lipid peroxidation in the etiology and pathogenesis of artherosclerosis (review), Vopr Med Khim, 35 (1989) 18-24
129. Stringer M D, Gorog P G, Freeman A, et al., Lipid peroxides and artherosclerosis, Brit Med J, 298 (1989) 281.
130. Duthie G G & Wahle K J, Smoking, antioxidants, essential fatty acids and coronary heart disease, Biochem Soc Transact, 18 (1990) 1051.
131. Esterbauer H, Dieber-Rotheneder M, Waeg G, Puhl H & Tatzber F, Endogenous antioxidants and lipoprotein oxidation, Biochem Soc Transat, 18 (1990) 1059.
132. Gey K F, The antioxidant hypothesis of cardiovascular disease: epidemiology and mechanisms, Biochem Soc Transact, 18 (1990) 1041.
133. Oliver M F, Linoleic acid, antioxidants and coronary heart disease, Biochem Soc Trans, 18 (1990) 1049.
134. Steinberg D, Antioxidants in the prevention of human atherosclerosis, Circulation, 85 (1992) 2337.
135. Gaziano J M, Manson J E, Buring J E & Hennekens C H, Dietary antioxidants and cardiovascular disease, Ann N Y Acad Sci, 669 (1992) 249.
136. Gaziano J M & Hennekens C H, Update on dietary antioxidants and cancer, Pathol Biol (Paris), 44(1) (1996) 42. Review
137. Enstrom J E, Kanim L E & Klein M A, Vitamin C intake and mortality among a sample of the United States population, Epidemiology, 3 (1992) 194.
138. Gey K F, Puska P & Moser U K, Inverse correlation between plasma vitamin E and mortality from ischemic heart disease in cross-cultural epidemiology, Am J Clin Nutr, 53 (1991) 326S.
139. Kaliora A C & Dedoussis GV, Natural antioxidant compounds in risk factors for CVD, Pharmacol Res, 56 (2007) 99.
140. Manson J E, Nathan D M, Krolewski A S, Stampfer M J, Willett W C & Hennekens C H, A prospective study of exercise and incidence of diabetes among US male physicians, JAMA, 268(1) (1992) 63.
141. Riemersma R A, Wood D A, Macintyre C C A, Elton R A, Gey K F & Oliver M F, Anti-oxidants and pro-oxidants in coronary heart disease, Lancet, 337 (1991) 1.
142. Stampfer M J, Hennekens C H, Manson J E, Colditz G A, Rosner B & Willett W C, Vitamin E consumption and the risk of coronary disease in women, N Eng J Med, 328 (1993) 1444.
143. Rimm E B, Stampfer M J, Aschrio A, Giovannucci E, Colditz G A & Willett W C, Vitamin E consumption and the risk of coronary heart disease in men, N Eng J Med, 328 (1993) 1450.
144. Steinberg D, Antioxidant vitamins and coronary heart disease, N Eng J Med, 328 (1993) 1487.
145. Golikovn A P, Polumiskov V J, Davydov B V et al., Lipid peroxidation and the major factors of its activation in patients with myocardial infarction, Cardiology, 29 (1989) 53.
146. Oldroyd K G, Chopra M, Rankin A C, Belch J J & Cobbe S M, Lipid peroxidation during myocard ischaemia induced by pacing, Brit Heart J, 63(2) (1990) 88.
147. Roth E, Torok B, Kellemen D et al., Free radical mediated injuries alter coronary artery occlusion, Basic Res Cardiol, 84(4) (1989) 388.
148. Hennig B & Chow C K, Lipid peroxidation and endothelial cell injury: Implications in atherosclerose, Free Radic Biol Med, 4 (1988) 99.
149. Ward P A,; Mechanisms of endothelial cell injury, J Lab Clin Med, 118 (1991) 421.
150. Halliwell B & Chirico S, Lipid peroxidation: Its mechanism, measurement, and significance, Am J Clin Nutr, 1993(suppl) 715S.
151. Steinbrecher U P, Zhang H & Longheed M, Role of oxidatively modified LDL in artherosclerosis, Free Radic Biol Med, 9 (1990) 155.
152. Brown M S, Basu S K, Palck J R, Ho Y K & Goldstein J L, The scavenger cell pathway for lipoprotein degradation; Specificity of the binding site that mediates the uptake of neatively charged LDL by macrophage, J Supramol Struct, 13 (1980) 67.
153. Brown M S & Goldstein J L, Lipoprotein metabolism in the macrophage; Implications for cholesterol deposition in stherosclerosis, Annu Rev Biochem, 52 (1983) 233.
154. Lehr H, Becker M, Marklund S L, Hübner C, Arfors K E, Kohlsch"tter A & Messmer K, Superoxide-dependent of leukocyte adhesion by oxidatively modified LDL in vivo, Arterioscler Thromb, 12 (1992) 824.
155. Palinski W, Rosenfeld M E, Ylä-Herttuala S, Gurtner G C, Sicher S A, Btuler S W, Parthasarathy S, Carew T E & Steinberg D, Low density lipoprotein undergoes oxidative modification in vivo, Proc Natl Acad Sci USA, 86 (1989) 1372.
156. Parthasarathy S &Steinberg D, Cell-induced oxidation of LDL, Curr Opin lipidol, 3 (1992) 313.
157. Sato K, Niki E & Shimasaki H, Free radical-mediated chain oxidation of low density lipoprotein and its synergistic inhibitation by vitamin E and vitamin C, Arch biochem Biophys, 279 (1990) 402.
158. Ylä-Herttuala S, Jaakkola O, Solakivi T, Kuivaniemi H & Nikkari T, The effect of proteoglycans, collagen and lysyl oxidase on the metabolism of low density lipoprotein by macrophages, Atherosclerosis, 62 (1986) 73.
159. Lyons T J, Glycation and oxidation: a role in the pathogenesis of atherosclerosis, Am J Cardiol, 71 (1993) 26B.
160. Goldstein J L, Ho Y K, Basu S K & Brown M S, Binding site on macrophages that mediates the uptake and degradation of acetylated low density lipoprotein producing massivecholesterol deposition, Proc Natl Acad Sci USA, 76 (1979) 333.
161. Parthasarathy S, Wieland E & Steinberg D, A role for endothelial cell lipoxygenase in the oxidative modification of low density lipoprotein, Proc Natl Acad Sci USA, 86 (1989) 1046.
162. Frei B, Ascorbic acid protects lipids in human plasma and the low-density lipoprotein against oxidative damage, Am J Clin Nutr, 54 (1991) 1113.
163. Esterbauer H, Dieber-Rotheneder M, Striegl G & Waeg G, Role of vitamin E in preventing the oxidation of low-density lipoprotein, Am J Clin Nutr, 53 (1991) S314.
164. Hiramatsu K, Rosen J W, Heincke K, Wolfbauer G & Chait A, Superoxide initiates oxidation of low density lipoprotein by human monocytes, Arteriosclerosis, 7 (1987) 55.
165. Favit A, Nicoletti F, Scapagnini U & Canonico P L, Ubiquinone protects cultured neurons against spontaneous and excitotoxin-induced degeneration, J Cereb Blood Flow Metab, 12. (1992) 638.
166. Nisticò G, Ciriolo M R, Fiskin K, Iannone M, De Martino A & Rotilio G, NGF restores decrease in catalase activity and increases superoxide dismutase and glutathione peroxidase activity in the brain of aged rats, Free Rad Biol Med, 12 (1992) 177.
167. Adams Jr. J D & Odunze I N, Oxygen free radicals and Parkinson's disease, Free Rad Biol. Med, 10 (1991) 161.
168. Behl C, Davis J, Cole G M & Schubert D Vitamin E protects nerve cells from amyloid beta protein toxicity, Biochem Biophys Res Commun, 186 (1992) 944.
169. Halliwell B, Oxygen radicals as key mediators in neurological disease: fact or fiction? Ann Neurol, 32 (1992) S10.
170. Floyd R A & Carney J M, Free radical damage to protein and DNA: mechanisms involved and relevant observations on brain undergoing oxidative stress, Ann Neurol, 32 (1992) S22.
171. Bindoli A, Rigobello M P & Deeble D J, Biochemical and toxicological properties of the oxidation products of catecholamines, Free Radicals Biol Med, 13 (1992) 391.
172. Fridovich I, Superoxide radical: an endogenous toxicant, Annu Rev Pharmacol Toxicol, 23 (1983) 239.
173. Halliwell B & Gutteridge J M C, (1984) Oxygen toxicity, oxygen radicals, transition metals and disease, Biochem J, 219 (1984) 11.
174. DiGuisepp J & Fridovich I, (1984) The toxicology of molecular oxygen, Critical Rev Toxicol, 12 (1984) 315.
175. Halliwell B, Free radicals, oxygen toxicity and aging, in Age pigments, edited by R S Sohal (Elsevier, Amsterdam) 1981.
176. Cohen G, Catalase, glutathione peroxidase, superoxide dismutase and cytochrome P-450 in the nervous system, in Handbook of neurochemistry, edited by A Lajtha (New York, Plenum Publishing) 1983.
177. Sinet P M, Heikkila R E & Cohen G, Hydrogen peroxide production by rat brain in vivo, J Neurochem, 34 (1980) 1421.
178. Sgaravatti A M, Sgarbi M B, Testa C G, Durigon K, Pederzolli C D, Prestes C C, Wyse A T, Wannmacher C M, Wajner M & Dutra-Filho C S, Gamma-hydroxybutyric acid induces oxidative stress in cerebral cortex of young rats, Neurochem Int, 50 (2007) 564.
179. Bannon M J, Goedert M & Williams B, The possible relation of glutathione, melanin and 1-methyl-4-phenyl-1,2,5,6- tetrahydropyridine (MPTP) to Parkinson's disease, Biochem Pharmacol, 33(17) (1984) 2697.
180. Davies C A, Mann D M A, Sumpter P Q & Yates P.O, A quantitative morphometric analysis of the neuronal and synaptic content of the frontal and temporal cortex in patients with AD, J Neurol Sci. 78 (1987) 151.
181. DeKosky S T & Scheff S W, Synapse loss in frontal cortex biopsies in AD correlation with cognitive severity, Ann Neurol, 27 (1990) 457.
182. Pearson R C A, Esiri M M, Hiorns RW, Wilcock G K &Powell T P S, Anatomical correlates of the distribution of the neocortex in AD, Proc Natl Acad Sci USA, 82 (1985) 1.
183. Hardy J & Allsop D, Amyloid deposition as the central event in the aetiology of AD, Trends Neurosci, 12 (1991) 383.
184. Martins R N, Harper C G, Stokes G B & Masters C L, Increased cerebral glucose-6-phosphate dehydrogenase activity in Alzheimer's disease may reflect oxidative stress, J Neurochem, 46 (1986) 1042.
185. Smith C D, Carney J M, Starke-Reed P E, Oliver C N, Stadtman E R, Floyd R A. & Markesbury W R, Excess brain protein oxidation and enzyme dysfunction in normal aging and in Alzheimer's disease, Proc Natl Acad Sci USA, 88 (1991) 10540.
186. Halliwell B, Reactive oxygen species and the central nervous system, J Neurochem, 59 (1992) 1609.
187. Harman D, Free radical theory of aging: a hypothesis on pathogenesis of senile dementia of the Alzheimer's type, Age, 16 (1993) 23.
188. Gotz M E, Kunig G, Riederer P, & Youdim M B H, Oxidative stress: free radical production in neuronal degeneration, Pharmacol Ther, 63 (1994) 37.
189. Mecocci P, MacGarvey U & Beal M F, Oxidative damage to mitochondrial DNA is increased in Allzheimer's disease, Ann Neurol, 36 (1994) 747.
190. Froelich L & Riederer P, Free radical mechanisms in dementia of Alzheimer type and the potential for anntioxidative treatment, Arzneimittelforschung Drug Res, 45 (1995) 443.
191. Gsell W, Conrad R, Hickethier M, Sofic E, Froelich L, Wichart I, Jellinger K, Moll G, Raansmaayr G, Beckmann H & Riederer P, Decreased catalase activity but unchanged superoxide dismutase activity in brains of patients with dementia of alzheimer type, J Neurochem, 64 (1995) 1216.
192. Friedlich A L & Butcher L L, Involvement of free oxygen radixcals in ß-amyloidosis: an hypothesis, Neurobiol Aging, 15 (1993) 443.
193. Nixon R A & Cataldo A M, Free radicals, proteolysis and the degeneration of neurons in Alzheimer disaese: how essential is the ß-amyloid link? Neurobiol Aging,15 (1994) 463.
194. Goedert M, Wischik C, Crowther R, Walker J & Klug A, Cloning and sequencing of the cDNA encoding a core protein of the paired helical filament of Alzheimer disease: identification as the microtubule-associated protein tau, Proc Natl Acad Sci USA, 85 (1988) 4051.
195. Kosik K, Alzheimer's disease: A cell biological perspective, Science, 256 (1993) 780.
196. Mukaetova-Ladinska E, Harrington C, Roth M & Wischik C, Biochemical and anatomical redistribution of tau protein in Alzheimer's disease, Am J Pathol, 143 (1993) 565.
197. Bendich A & Butterworth Jr. C E, Micronutrients in health and in disease prevention (Marcel Dekker, New York) 1991.
198. Gaby, S K, Bendich, A, Singh, V N & Machlin, L J, Vitamin intake and health (Marcel Dekker, New York) 1991.
199. Zaman Z, Roche S, Fielden P, Frost P G, Niriella D C & Cayley A C D, Plasma concentrations of vitamins A and E and carotenoids in Alzheimer's disease, Age Ageing, 21 (1992) 91.
200. Jesberger J A & Richardson J S, Oxygen free radicals and brain dysfunction, Int J Neurosci, 57 (1991) 1.
201. Rosen D R, Siddique T, Patterson D, Figlewicz D A, Sapp P, Hentati A, Donaldson D, Goto J, O'Regan J P, Deng H-X et al., Mutations in Cu/Zn superoxide dismutase gene are associated with familial amyotrophic lateral sclerosis, Nature, (1993) 59.
202. Martinez-Cayuela M, Oxygen free radicals and human disease, Biochimie, 77 (1995) 147.
203. Henle K J & Dethlefsen L A, Time-temperature relationships for heat-induced killing of mammalian cells, Ann N Y Acad Sci, 335 (1980) 234.
204. Craig E A, The heat shock response, CRC Crit Rev Biochem, 18(3) (1985) 239.
205. Slater A, Cato A C B, Sillar G M, Kioussis J & Burdon R H, The pattern of protein synthesis induced by heat shock of HeLa cells, Eur J Biochem, 117 (1981) 341.
206. Burdon R H in Hyperthermie oncology, edited by J Overgaard (Taylor & Francis, London) 1984, 223
207. Lee P C, Bochner B R & Ames B N, AppA, heat-shock stress, and cell oxidation, Proc Natl Acad Sci USA, 80 (1983) 7496.
208. Morgan R W, Chritsman M F, Jacobson F S, Story G & Ames B N, Hydrogen peroxide-inducible proteins in Salmonella typhimurium overlap with heat shock and other stress proteins, Proc Natl Acad Sci USA, 83 (1986) 8063.
209. Christman M F, Morgan R W, Jacobson F S & Ames B N, Positive control of a regulon for defenses against oxidative stress and some heat-shock proteins in Salmonella typhimurium, Cell, 41 (1985) 753.
210. Loven D P, Leeper D B & Oberley LW, Superoxide dismutase levels in Chinese hamster ovary cells and ovarian carcinoma cells after hyperthermia or exposure to cycloheximide, Cancer Res, 45 (1985) 3029.
211. Levinson W, Mikelens P, Oppermann H & Jackson J, Effect of antabuse (disulfiram) on Rous sarcoma virus and on eukaryotic cells, Biochem Biophys Acta, 519 (1978) 65.
212. Omar R A, Yano S & Kikkawa Y, Antioxidant enzymes and survival of normal and simian virus 40-transformed mouse embryo cells after hyperthermia, Cancer Res, 47(13) (1987) 3473.
213. McCord J M, Superoxide dismutase: rationale for use in reperfusion injury and inflammation, J Free Radic Biol Med, 2 (1986) 325.
214. Hass M A & Massaro D, Rugulation of the synthesis of superoxide dismutases in rat lungs during oxidant and hyperthermic stresses, J Biol Chem, 263 (1989) 776.
215. Currie R W, Karmazyn M, Kloc M & Mailer K, Heat shock response is associated with enhanced postichemic ventricular recovery, Circ Res, 63 (1988) 543.
216. Nohl H & Jordan W, The metabolic fate of mitochondrial hydrogen peroxide, Int J Biochem, 111 (1980) 203.
217. Yellon D M, Pasini E, Cargnoni A, Marber M, Latchman, D S & Ferrari R, The protective role of heat stress in the ischemic and reperfused rabbit myocardium, J Mol Cell Cardiol, 24 (1992) 895.
218. Karmazyn M, Mailer K & Vurrie R W, Acquisition and decay of heat shock enhanced post ischemic ventricular recovery, Am J Physiol, 259 (1990) H424.
219. Walker D M, Pasini E, Kuckoglu S, Marber M, Iliodromitis E, Ferrari R & Yellon D M, Heat stress limit infarct size in the isolated perfused rabbit heart, Cardiovasc Res, 27 (1993) 962.
220. Donnelly T J, Sievers R E, Vissern F L J, Welch W J & Wolfe C L, Heat shock protein induction in rat hearts, Circulation, 85 (1992) 769.
221. Ritossa F, A new puffing pattern induced by temperature shock and DNP in Drosophila, Experimentia, 18 (1962) 571.
222. Georgopoulos C & Welch W J, Role of the major heat shock proteins as molecular chaperones, Annu Rev Cell Biol, 9 (1993) 601.
223. Hightower L E, Heat shock, stress proteins, chaperones proteoxicity, Cell, 66 (1991) 191.
224. Ellis R J, Protein misassembly: macromolecular crowding and molecular chaperones, Adv Exp Med Biol, 594 (2007) 1.
225. Ellis R J, Macromolecular crowding: Obvious but underappreciated, Trends Biochem Sci, 26 (2001) 597.
226. Lashuel H A, Hartley D, Petre B M, et al., Neurodegenerative disease: Amyloid pores from pathogenic mutations, Nature, 418 (2002) 291.
227. Satyal S H, Schmidt E, Kitagawa K, et al., Polyglutamine aggregates alter protein folding homeostasis in Caenorhabditis ellegans, Proc.Natl Acad Sci USA, 97 (2000) 5750.
228. Ben-Zvi A P & Goloubinoff P, Proteinaceous infectious behavior in nonpathogenic proteins is controlled by molecular chapperones, J Biol Chem, 277 (2002) 49422.
229. Tomoyasu T, Mogk A, Laangen H, et al., Genetic dissection of the roles of chaperones and proteases in protein folding and degradation in the Escherichia coli cytosol, Mol Microbiol, 40 (2001) 397.
230. Dingwall C & Lasky R A, Nucleoplasmin: The archetypal molecular chaperone, Semin Cell Biol, 1 (1990) 11.
231. Ellis R J, Discovery of molecular chaperones, Cell Stress Chaperones, 1 (1996) 155.
232. Shtilerman M, Lorimer G H & Englander S W, Chaperonin function: Folding by forced unfolding, Science, 284 (1999) 822.
233. Ben-zvi A P & Goloubinoff P, Review: Mechanisms of disaggregation and refolding of stable protein aggregation by molecular chaperones, J Struct Biol, 135 (2001) 84.
234. Westerheide S D & Morimoto R I, Heat shock response modulators as therapeutic tools for diseases of protein conformation, J Biol Chem, 280 (2005) 33097.
235. Chatellier J, Hill F & Fersht A.R, From minichaperone to GroEL 2: Importance of avidity of the multisiti ring structure, J Mol Biol, 304 (2000) 883.
236. Mogk A, Tomoyasu T, Goloubinoff P, Rüdiger S, Röder D, Langen H & Bukau B, Identification of thermolabile Eschericchia coli proteins, Prevention and reversion of aggregation by DnaK and ClpB, EMBO J, 18 (1999) 6934.
237. Goloubinoff P, Christeller J T, Gatennby A A, et al., Reconsstition of active dimeric ribulose bisphosphatechaperonin proteins and Mg-ATP, Nature, 342 (1989) 884.
238. Goloubinoff P, Moggk A, Zvi A P, et al., Sequential mechanism of solubilization and refolding of stable protein aggregates by a bichaaperone network, Proc Natl Acad Sci USA, 96 (1999) 13732.
239. Ellis R J, Revisiting the Anfinsen cage, Folding and Design, 1 (1996) R9.
240. Hinault M P & Goloubinoff P, Molecular chaperonesn and proteases: Cellular fold-controlling factors of proteins in neurodegenerative diseases and aging, J Mol Neurosci, (2006) (In Press).
241. Heydari A R, You S, Takahashi R, et al., Age-related alterations in the activation of heat shock transcription factor 1 in rat hepatocytes, Exp Cell Res, 256 (2000) 83.
242. Soti C & Csermely P, Aging and molecular chaperones, Exp Gerontol, 38 (2003) 1037.
243. Saleh A, Srinivasula S M, Balkir L, et al., Negative regulation of the Apaf-1 apoptosome by HSP70, Natl Cell Biol, 2 (2000) 476.
244. Waang Q, Mosser D D & Bag J, Induction of HSP70 expression and recruitment of HSC70 and HSP70 in the nucleus reduce aggregation of a polyalanine expansion mutant of PABPN1 in HeLa cells, Hum Mol Genet,14 (2005) 3673.
245. Westerheide S D, Bosman J D, Mbadugha B N, et al., Celastrols as inducers of the heat shock response and cytoprotection, J Biol Chem, 279 (2004) 566053.
246. Delmas D, Jannin B & Latruffe N, Resveratrol: Preventtingg properties agaainst vascular alterations and ageing, Mol Nutr Food Res, 49 (2005) 377.
247. Ooie T, Takkaahhashi N & Saikawa T, Single oral dose of genanylgeranylacetone induces heat-shock prrotein 72 and renders protection against ischemia/reperfusion injury in rat heart, Circulation, 1104 (2001) 1837.
248. Haddad J J, Sciennce review: Redox and oxygen-sensitive transcription factors in the regulation of oxidant-mediated lung injury: Role for nuclear factor-kappaB, Crit Care, 6 (2002) 481.
249. Lopez-Neblina F, Toledo A.H & Toledo-Pereyra L H, Molecular biology of apoptosis in ischemia and reperfusion, J Invest Surg, 18 (2005) 335.
250. Lopez-Neblina F, Toledo A.H & Toledo-Pereyra L H, Molecular biology of apoptosis in ischemia and reperfusion, J Invest Surg, 18 (2005) 335. 246 Peper A, Grimbergen C A, Spaan J A E, Souren J E M & Van Wijk R, A mathematical model of the HSP70 regulation in the cell, Int J Hyperthermia 14 (1998) 97.
251. Alam J & Cook J L, How many transcription factors does it take to turn on the heme oxygenase-1 gene? Am J Respir Cell Mol Biol, 36 (2007) 166.
252. Wiegant F A C, Souren J E M, Van Rijn J & Van Wijk R, Stressor-specific induction of heat shock proteins in rat hepatoma cells, Toxicology 94 (1994) 143.
253. Poss K D & Tonegawa S, Reduced stress defense in heme oxygenase 1-deficient cells, Proc Natl Acad Sci USA, 94 (1997) 10925.
254. Maines M D, The heme oxygenase system: past, present and future, Antioxid Redox Signal, 6 (2004) 797.
255. Ryter S, Alam J & Choi A M, Heme oxygenase-1 / carbon monoxide: from basic science to therapeutic application, Physiol Rev, 85 (2006) 583.
256. Vitek L & Schwertner H A, The heme catabolic pathway and its protective effects on oxidative stress-mediated diseases, Adv Clin Chem, 43 (2007) 1.
257. Stocker R, Yamamoto Y, McDonagh A F, Glazer A N & Ames B N, Bilirubin is an antioxidant of possible physiological importance, Science, 235 (1987) 1043.
258. Scott J R, Chin B Y, Bilban M H & Otterbein L E, Restoring Homeostasis. Is heme oxygenase-1 ready for the clinic? Trends Pharmacol Sci, 28 (2007) 200.
259. Schipper H M, Heme oxygenase expression in human central nervous disorders, Free Radical Biol Med, 37 (2004) 1995.
260. Wiegant F A C, Souren J E M & Van Wijk R, Stimulation of survival capacity in heat shocked cells by subsequent exposure to minute amounts of chemical stressors; role of similarity in HSP-inducing effects, Hum Exp Toxicol, 18 (1999) 460.
261. Kakizuka A, Protein precipitation: A common etiology in neurodegenerative disorders? Trends Genet, 14 (1998) 396.
262. Kopito R R & Ron D, Conformational disease, Nat Cell Biol, 2 (2000) E207.
263. Stefani M & Dobson C M, Protein aggregation and aggregate toxicity: New insights into protein folding, misfolding diseases and biological evolution, J Mol Med, 81 (2003) 678.
264. Hayden M R, Tyagi S C, Kerklo M M & Nicolls M R, Type 2 diabetes Mellitus as a conformational disease, JOP J Pancreas, 6 (2005) 287.
265. Dobson C.M, Protein folding and its links with human disease, Biochem Soc Symp, 68 (2001) 1.
266. Cumming R C, Andon N L, Haynes P A, Park M, Fischer W H & Schubert D, Protein disulfide bond formation in the cytoplasm during oxidative stress, J Biol Chem, 279 (2004) 21749.
267. Anelli T, Alessio M, Mezghrani A, Simmen T, Talamo F, Bachi A & Sitia R, ERp44, a novel ndoplasmic reticulum folding assistant of the thioredoxin family, EMBO J, 21 (2002) 835.
268. Fassio A & Sitia R, Formation, isomerisation and reduction of disulphide bonds during protein quality control in the endoplasmic reticulum, Histochem Cell Biol, 117 (2002) 151.
269. Zou M H, Cohen R & Ullrich V, Peroxynitrite and vascular endothelial dysfunction in diabetes mellitus. Endothelium 2004; 11:89-9.
270. Adeghate E, Parvez SH. Nitric oxide and neuronal and pancreatic beta cell death, Toxicology, 153 (2000) 143.
271. Adeghate E & Parvez S H, Nitric oxide and neuronal pancreatic beta cell death, Toxicology, 153 (2000) 143.
272. Turko I V, Marcondes S & Murad F, Diabetes-associated nitration of tyrosine and inactivation of succinyl-CoA:3- oxoacid CoA-transferase, Am J Physiol Heart Circ Physiol, 281 (2001) H2289.
273. Hayden M R & Tyagi S C, Islet redox stress: the manifold toxicities of insulin resistance, metabolic syndrome and amylin derived islet amyloid in type 2 diabetes mellitus, JOP J Pancreas, 3 (2002) 86.
274. Adeghate E, Molecular and cellular basis of the aetiology and management of diabetic cardiomyopathy: a short review, Mol Cell Biochem, 261 (2004) 187.
275. Cowell R M & Russell J W, Nitrosative injury and antioxidant therapy in the management of diabetic neuropathy, J Investig Med, 52 (2004) 33.
276. Butler A E, Janson J, Soeller W C & Butler P C, Increased beta-cell apoptosis prevents adaptive increase in beta-cell mass in mouse model of type 2 diabetes: evidence for role ofislet amyloid formation rather than direct action of amyloid, Diabetes, 52 (2003) 2304.
277. Janson J, Ashley R H, Harrison D, McIntyre S & Butler P C, The mechanism of islet amyloid polypeptide toxicity is membrane disruption by intermediate-sized toxic a myloid particles, Diabetes, 48 (1999) 491.
278. Ritzel R A & Butler P C, Replication increases beta-cell vulnerability to human islet amyloid polypeptide-induced apoptosis, Diabetes, 52 (2003) 1701.
279. Kahn S E, Andrikopoulos S & Verchere C B, Islet amyloid: a long-recognized but underappreciated pathological feature of type 2 diabetes, Diabetes, 48 (1999) 241.
280. Butler A E, Jang J, Gurlo T, Carty M D, Soeller W C & Butler P Cl, Diabetes due to a progressive defect in beta-cell mass in rats transgenic for human islet amyloid polypeptide (HIP Rat): a new model for type 2, Diabetes, 53 (2004) 1509.
281. Hayden M R & Tyagi S C, 'A' is for amylin and amyloid in type 2 diabetes mellitus, JOP J Pancreas, 2 (2001) 124-139
282. Clark A, de Koning E J, Hattersley A T, Hansen B C, Yajnik C S & Poulton J, Pancreatic pathology in non-insulin dependent diabetes (NIDDM), Diabetes Res Clin Pract, 28(Suppl) (1995) S39.
283. Papa S, Mitochondrial oxidative phosphorylation changes in the life span. Molecular aspects and physiopathological implications, Biochim Biophys Acta,1276 (1996) 87.
284. 279 Wei Y H, Oxidative stress and mitochondrial DNA mutations in human aging, Proc Soc Exp Biol Med, 217 (1998) 53.
285. Sohal R S & Sohal B H, Hydrogen peroxide release by mitochondria increases during aging, Mech Aging Dev, 57 (1991) 187.
286. Richter C, Gogvadze V, Laffranchi R, Schlapbach R, Schnizer M, Suter M, Walter P & Yaffee M, Oxidants in mitochondria: from physiology to disease, Biochim Biophys Acta, 1271 (1995) 67.
287. Sohal R S, Sohal B H. & Orr W C, Mitochondrial superoxide and hydrogen peroxide generation, protein oxidative damage and longevity in different species of flies, Free Radical Biol. Med, 19 (1995) 499.
288. Lee H C, Lu C Y, Fahn H J & Wei Y H, Aging- and smoking-associated alteration in the relative content in human lung, FEBS Lett, 441 (1998) 292.
289. Fahn H J, Wang L S, Hsieh R H, Chang S C, Kao S H, Huang M H & Wei Y H, Age-related 4,977 bp deletion in human lung mitochondrial DNA, Am J Respir Crit Care Med, 154 (1996) 1141.
290. Lee H C, Lim M L R, Lu C Y, Liu V W S, Fahn H J, Zhang C, Nagley P & Wei Y H, Concurrent increase of oxidative DNA damage and lipid peroxidation together with mitochondrial DNA mutation in human lung tissues during aging-smoking enhances oxidative stress on the aged tissues, Arch Biochem Biophys, 362 (1999) 309.
291. Wei Y H, Kao S H & Lee H C, Simultaneous increase of mitochondrial DNA deletions and lipid peroxidation in human aging, Ann N Y Acad Sci, 786 (1996) 24.
292. Lu C Y, Lee H C, Fahn H J & Wei Y H, Oxidative damage elicited by imbalance of free radical scavenging enzymes is associated with large-scale mtDNA deletions in aging human skin, Mutat Res, 423 (1991) 11.
293. Ames B N, Shigenage K & Hagen T M, Mitochondrial decay in aging, Biochim Biophys Acta, 1271 (1995) 165.
294. Lee H C, Yin P H, Lu C Y, Chi C W & Wei Y H, Increase of mitochondria and nitochondrial DNA in response to oxidative stress in human cells, Biochem J, 348 (2000) 425.
295. Bonini N M, Chaperoning brain degeneration, Proc Natl Acad Sci USA, 99 (2002) 16407.
296. Chan H Y, Warrick J M, Andriola I, et al., Genetic modulation of polyglutamine toxicity by protein conjugation pathways in Drosophila, Hum Mol Genet, 11 (2002) 2895.
297. Cummings C J, Mancini M A, Antalffy B, et al., Chaperone suppression of aggregation and alterred subcellular proteasome localization imply protein misfolding in SCA1, Nat Genet, (1998) 148.
298. Kawaguchi T, Okamoto T, Taniwaki M, et al., CAC expansions in a novel gene for Machado-Joseph disease at chromosome 14q32.1, Nat Genet, 8 (1994) 221.
299. Koide R, Ikeuchi T, Onodera O, et al., Unstable expansion of CAC repeat in hereditary dentatorubral-pallidoluysian atrophy (DRPLA), Nat Genet, 6 (1994) 9.
300. La Spada A R, Wilson E M, Lubahn D R, et al., Androgen receptor gene mutations in X-linked spinal and bulbar muscular atrophy, Nature, 352 (1991) 77.
301. Orr H T, Chung M Y, Banfi, et al., Expansion of an unstable trinucleotide CAG repeat in spinocerebellar ataxia type 1, Nat Genet, 4 (1993) 221.
302. Kamino K, Orr H T, Payami H, et al., Linkage and mutational analysis of familial Alzheimer disease kindreds for the APP gene region, Am J Hum Genet, 51 (1992) 998.
303. Laing N G & Siddique T, Cu/Zn superoxide dismutase gene mutations in amyotrophic lateral sclerosis: Correlation between genetype and clinical features, J Neurosurg Psychiatry, 63 (1997) 815.
304. Lucking CB, Durr A, Bonifati V, et al., Association between early-onset of Parkinson's disease and mutations in the parkin gene, French Parkinson's Disease Genetics Study Group, N Engl J Med, 342 (2000) 1560.
305. Mizuno Y, Hattori N, Kitada T, et al., Familial Parkinson's disease, Alpha-synuclein and parkin, Adv Neurol, 86 (2001) 13.
306. Polymeropoulos M H, Lavedan C, Leroy E, et al., Mutation in the alpha-synuclein gene identified in families with Parkinson's disease, Science, 2276 (1997) 2045.
307. Rosen D R, Siddique T, Patterson D, et al., Mutations in Cu/Zn superoxide dismutase gene are associated with familial amyotrophic lateral sclerosis, Nature, 362 (1993) 59.
308. Driscoll M & Gerstbrein B, Dying for a cause: Invertebrate genetics takes on human neurodegeneration, Nat Rev Genet, 4 (2003) 181.
309. Link C D, Transgenic invertebrate models of age-associated neurodegenerative diseases, Mech Ageing Dev, 122 (2001) 1639.
310. Thompson L M & Marsh J L, Invertebrate models of neurologic disease: Inssights into pathogenesis and therapy, Curr Neurol Neurosci Rep, 3 (2003) 442.
311. Westlund B, Stilwell G & Sluder A, Invertebrate disease models in neurotherapeutic discovery, Curr Opin Drug Discov Devel, 7 (2004) 169.
312. Merry D E, Animal models of Kennedy disease, NeuroRx, 2 (2005) 471.
313. Ross C A & Poirier M A, Protein aggregation and neurodegenerative disease, Nat Med, 10 (2004) S10.
314. Brignull, H.R., Morley J.F., Morimoto R.I. The stress of misfolded proteins: C. elegans models for neurodegenerative disease and aging, disease and aging, in Molecular aspects of the stress response: Chaperones, Membranes and Networks, edited by P Csermely & L Vígh (Springer, New York) 2006, 167.
315. Garigan D, Hsu A L, Fraser A G, et al., Genetic analysis of tissue aging in Caenorhabditis elegans; A role for heat-shock factor and bacterial proliferation, Genetics, 161 (2002) 1101.
316. Hsu A L, Murphy C T & Kenyon C, Regulation of aging and age-related disease by DAF-16 and heat-shock factor, Science, 300 (2003) 1142.
317. Morley J F & Morimoto R I, Regulation of longevity in Caenorhabditis elegans by heat shock factor and molecular chaperones, Mol Biol Cell, 15 (2004) 657.
318. Gutteridge J M C & Halliwell B, The measurement and mechanisms of lipid peroxidation in biological systems, Trends Biochem Sci, 15 (1990) 129.
319. Boveris A, Cadenas E & Chance B, Low level chemiluminescence of the lipoxygenase reaction, Photobiochem Photobiophys,1 (1980) 175.
320. Slawinski J, Luminescence research and its relation to ultra weak cell radiation, Experientia, 44 (1988) 559.
321. Boveris A, Cadenas E, Reiter R, Filipkowski M, Nakase Y & Chance B, Organ chemiluminescence: Non-invasive assay for oxidative radical reactions, Proc Natl Acad Sci USA, 77 (1980) 347.
322. Harvey E N, Living light (Princeton University Press, Princeton) 1940.
323. Harvey E N, A History of luminescence (American Philosophical Society, Philadelphia, Pennsylvania) 1957
324. Troitskii N A, Konev S V & Katibnikov M A, Investigation of the ultraviolet hemi luminescence of biological systems, Biofizika, 6(2) (1961) 80.
325. Vladimirov IuA, Litvin F F & T'an M C, On the problem of the role of the nature of ultraweak luminescence in biological systems, Biofizika, 7 (1962) 675.
326. Seliger H H & McElroy W D, Spectral emission and quantum yield of firefly bioluminescence, Arch Biochem Biophys, 88 (1960) 136.
327. Stauff J & Reske G, Model studies on chemical carcinogenesis and on the photodynamic effect of 3,4 - Benzopyrene and UV light in aqueous protein solutions with different SH group reactivity, Z Naturforsch B, 19 (1964) 716.
328. Quickenden T I & Quee Hee S S, Weak luminescence from the yeast Saccharomyces cerevisiae and the existence of mitogenetic radiation, Biochem Biophys Res Commun, 60 (1974) 764.
329. Allen R C, Stjernholm R L & Steele R H, Evidence for the generation of an electronic excitation state(s) in human polymorphonuclear leukocytes and its participation in bactericidal activity, Biochem Biophys Res Commun, 47 (1972) 79.
330. Kakinuma K, Cadenas E, Boveris A & Chance B, Low level chemiluminescence of intact polymorphonuclear leukocytes, FEBS Lett, 102 (1979) 38.
331. Cadenas E, Daniele R P & Chance B, Low level chemiluminescence of alveolar macrophages: spectral evidence for singlet oxygen generation, FEBS Lett, 123 (1981) 225.
332. Cadenas E, WefersH & Sies H, Low-level chemiluminescence of isolated hepatocytes, Eur J Biochem 119, (1981) 531.
333. Pirenne M H & Denton E J, Accuracy and sensitivity of the human eye, Nature, 170 (1952) 1039.
334. Nakano M, Noguchi T, Sugioka K, Fukuyama H, Sato M, Shimizu Y, Tsuji Y & Inaba H, J Biol Chem, 250 (1975) 2404.
335. Sugioka K & Nakano M, A possible mechanism of the generation of singlet molecular oxygen in nadph-dependent microsomal lipid peroxidation, Biochim Biophys Acta, 423 (1976) 203.
336. Hamman J P, Gorby D R & Selige.H H, A new type of biological chemiluminescence: the microsomal chemiluminescence of benzo[a]pyrene arises from the diol epoxide product of the 7,8-dihydrodiol, Biochem Biophys Res Commun, 75, (1977) 793.
337. Scarpa A Dutton P L & Leigh J S, Frontiers of biological energetics: From electron to tissues (Academic Press, New York) 1978.
338. Cadenas E, Boveris A & Chance B, Low-level chemiluminescence of bovine heart submitochondrial particles, Biochem J, 186 (1980) 659.
339. King M M, Lai E K & McCay P B, Singlet oxygen production associated with enzyme-catalyzed lipid peroxidation in liver microsomes, J Biochem, 250 (1975) 6496.
340. Hatefi Y & Hanstein W G, Lipid oxidation in biological membranes. I. Lipid oxidation in submitochondrial particles and microsomes induced by chaotropic agents, Arch Biochem Biophys, 138 (1970) 73.
341. 335A.Hanstein W G & Hatefi Y, Lipid oxidation in biological membranes. II. Kinetics and mechanism of lipid oxidation in submitochondrial particles, Arch Biochem Biophys, 138(1) (1970) 87.
342. Tappel A L, Studies of the mechanism of vitamin E action. III. In vitro copolymerization of oxidized fats with protein, Arch Biochem Biophys, 54 (1955) 266.
343. Misra H & Fridovich I, A peroxide-dependent reduction of cytochrome c by NADH, Biochem Biophys Acta, 292 (1973) 815.
344. McCord J M & Day jr. E D, Superoxide-dependent production of hydroxyl radical catalyzed by iron-EDTA complex, FEBS Lett, 86 (1978) 139.
345. Halliwell B, Superoxide-dependent formation of hydroxyl radicals in the presence of iron chelates: is it a mechanism for hydroxyl radical production in biochemical systems? FEBS Lett, 92 (1978) 321.
346. Cohen G. in Superoxide and superoxide dismutases, edited by A M Michelson, J M McCord & I. Fridovich (Academic Press, New York) 1977, 317.
347. Peters J W & Foote C S, Chemistry of superoxide ion. II. Reaction with hydroperoxides, J Am Chem Soc, 98 (1976) 873.
348. Cadenas E, Vasavsky A I, Boveris A & Chance B, Oxygenor organic hydroperoxide-induced chemiluminescence of brain and liver homogenase, Biochem J, 198 (1981) 645.
349. 2 utilization, Free Rad Biol Med, 2 (1986) 135.
350. Riely C A, Cohen G & Lieberman M, Ethane evolution: a new index of lipid peroxidation, Science, 183 (1974) 208.
351. Dillard C J, Dumelin E E & Tappel A L, Effect of dietary vitamin E on expiration of pentane and ethane by the rat, Lipids, 12 (1977) 109.
352. Okuda M, Lee H C, Kumar C & Chance, Oxygen radical generation during ischemia-reperfusion in the isolated perfused rat liver monitored by enhanced chemiluminescence, Circulatory Shock, 38 (1992) 228.
353. Bachmann E, Weber E & Zbinden G, Effects of seven anthracycline antibiotics on electrocardiogram and mitochondrial function of rat hearts, Agents Actions, 5 (1975) 383.
354. Barnard M L, Gurdian S & Turrens J F, Activated polymorphonuclear leukocytes increase low-level chemiluminescence of isolated perfused rat lungs, J Appl Physiol, 75 (1993) 933.
355. Fukuda F, Kitada M, Horie T & Awazu S, Evaluation of adriamycin-induced lipid peroxidation, Biochem Pharmacol, 44 (1992) 755.
356. Doroshow J H & Davies K J A, Redox cycling of anthracyclines by cardiac mitochondria. II. Formation of superoxide anion, hydrogen peroxide and hydroxyl radical, J Biol Chem, 261 (1986) 3068.
357. Sugioka K, Nakano H, Nakano M, Tero-Kubota S &Ikegami Y., Generation of hydroxyl radicals during the enzymatic reductions of the Fe'.-ADP-EDTA systems, Less unvolvement of hydroxyl radical and a great importance of proposed perferryl ion complexes in lipid peroxidation, Biochim Biophys Acta, 753 (1983) 411.
358. Meerson F Z, Kagan V E, Kozlov Yu P, Belinka L M & Arkhipenko Yu V, The role of lipid peroxidation in pathogenesis of ischemic damage and the antioxidant protection of the heart, Basic Res Cardiol, 77 (1982) 465.
359. Meerson F Z, Belkina L M, Sazontova T G, Saltykova V A & Arkhipenko Yu V, The role of lipid peroxidation in the pathogenesis of arrhythmias and prevention of cardiac fibrillation with antioxidant, Basic Res.Cardiol, 82 (1987) 123.
360. Guarnieri C, Flamigni F & Caldarera C M, Role of oxygen in the cellular damage induced by reoxygenation of hypoxic heart, J Mol Cell Cardiol, 12 (1980) 797.
361. Chambers D E, Parks D A, Patterson G, Yoshida S, Burton K, Parmley L F, McCord J & Downey J M, Role of oxygen derived radicals in myocardial ischemia, Feder Proc, 42 (1983) 1093.
362. Kramer J H, Arroyo C M, Dickens B F & Weglicki W B, Spin-trapping evidence that graded myocardial ischemia alters post-ischemic superoxide production, Free Radic Biol Med, 3 (1987) 153.
363. Garlick P B, Davies M J, Hearse D J & Slater T S, Direct detection of free radicals in the reperfused rat heart using electron spin resonance spectroscopy, Circul Res, 61 (1987) 757.
364. Arroyo C M, Kramer J H, Leiboff R H, Mergner G W, Dickens B F & Weglicki W B, Spin trapping of oxygen and carbon centered free radicals in ischemic canine myocardium, Free Rad Biol Med, 5 (1987) 313.
365. Barsacchi R, Coassin M, Maiorino M, Pelosi G, Simonelli C & Ursini F, Increased ultra weak chemiluminescence from rat heart at postischemie reoxygenation: protective role of vitamin E, Free Rad Biol & Medic, 5 (1989) 573.
366. Parks D A & Granger D N, Ischemia-reperfusion injury: A radical view, Hepatology, 8 (1988) 680.
367. Nunes F A, Kumar C, Chance B & Brass C A, Chemiluminescent measurement of increased free radical formation after ischemia/reperfusion, Digestive Diseases and Sciences, 40(5) ( 1995) 1045.
368. Adkinson D, Hollwarth M E, Benoit J N, Parks D A, McCord J M & Granger D N, Role of free radicals in ischemiareperfusion in jury to the liver, Acta Physiol Scand, (Suppl) 548 (1986) 101.
369. Atalla S L, Tolodo-Pereyra L H, MacKenzie G H & Cederna J P, Influence of oxygen-derived free radical scavengers on ischemic livers, Transplantation, 40 (1985) 584.
370. Cadenas E, Boveris A, & Chance B, Low-level chemiluminescence of biological systems, in Free radical in biology,edited by W A Pryor (New York, Academic Press) 1984, 211.
371. Cadenas E, Arad I D, Boveris A, Fisher A B & Chance B, Partial spectral analysis of the hydroperoxide-induced chemiluminescence of the perfused lung, FEBS Lett, 111 (1980) 413.
372. Turrens J F, Giulivi C, Pinus C R, Lavagno C & Boveris A, Spontaneous lung chemiluminescence upon paraquat administration, Free Rad Biol Med, 5 (1988) 319.
373. Barnard M L, Gurdian S & Turrens J F, Activated polymorphonuclear leukocytes increase low-level chemiluminescence of isolated perfused rat lungs, J Appl Physiol, 75 (1993) 933.
374. Peralta J G, Barnard M L & Turrens J K, Characteristics of neutrophil influx in rat lungs following fecal peritonitis, Inflammation, 17 (1993) 263.
375. Cilento G, Photobiochemistry without light, Experientia, 44 (1988) 572.
376. Ntziachristos V, Ripoll J, Wang L V, Weissleder R, Looking and listening to light: the evolution of whole body photonic imaging. Nature Biotechnol, 23 (2005) 313.
377. Kobayashi M, Takeda M, Ito, K-I, Kato H & Inaba H, Twodimensional photon counting imaging and spatiotemporal characterization of ultraweak photon emission from a rat's brain in vivo, J Neurosci Methods, 93 (1999) 163.
378. st century, edited by X Shen & R Van Wijk (Springer, New York) 2005, 155.
379. Boveris A, Llesuy S F & Fraga C G, Increased liver chemiluminescence in tumor-bearing mice, J Free Rad Biol Med, 1(2) (1985) 131.
380. Neifakh E A, Free-radical mechanism of ultraweak chemiluminescence accompanying the peroxidation of unsaturated fatty acids, Biofizika, 16 (1971) 560.
381. Greenstein J P, Biochemistry of cancer, (Academic Press, New York) 1947, 202
382. Amano T, Kunimi K, Nakashima K, Uchibayashi T & Hisazumi H, A combined therapy of hyperthermia and tumor necrosis factor for nude mice bearing KK-47 bladder cancer, J Urol, (1990) 144.
383. Amano T, Kobayashi M, Devaraj B, Inaba H, Ultraweak biophoton emission imaging of transplanted bladder cancer, Urol Res, 23 (1995) 315
384. Kim J, Choi C, Lim J, You H, Sim S, Yom Y, Kim E & Soh K, Measurements of spontaneous photon emission and delayed luminescence from human cancer tissues, J Altern Complement Med, 11 (2005) 879.
385. Shimizu Y, Inaba H, Kumaki K, Mizuno K, Hata S & Tomita S, Measuring methods for ultra-low light intensity and their application to extra-weak spontaneous bioluminescence from living tissues, IEEE Trans Instrum Meas, IM-22 (1973) 153.
386. Takeda M, Kobayashi M, Takayama M, Suzuki S, Ishida T, Ohnuki K, Moriya T & Ohuchi N, Biophoton detection as a novel technique for cancer imaging, Cancer Sci, 95 (2004) 656.
387. Dobrin R, Kirsch C, Kirsch S, Pierrakos J, Schwartz E, Wolff T & Zeira Y, Experimental measurements of the human energy field, in Psychoenergetic systems: The interface of consciousness, energy and matter, edited by S Krippner (Gordon & Breach, New York) 1979, 227.
388. Dobrin R, Kirsch C, Kirsch S, Pierrakos J, Schwartz E, Wolff T Zeira, Y, Experimental measurements of the human energy field, in The Energies of Consciousness, edited by S Krippner & D Rubin (Gordon and Breach New York), 1975.
389. Cohen S & Popp F A, Whole-body counting of biophotons and its relation to biological rhythms, in Biophotons, edited by J J Chang, J Fisch & F A Popp (Kluwer Academic, Dordrecht) 1998, 183.
390. Sauermann G, Mei W P, Hoppe U & Stäb F, Ultraweak photon emission of human skin in vivo: Influence of topically applied antioxidants on human skin, Methods Enzymol, 300 (1999) 419.
391. Choi C, Woo W M, Lee M B, Yang J S, Soh K S, Yang J S, Yoon G, Kim M, Zaslawsky & Chang J J, Biophoton emission from the hands, J Korean Physical Soc, 41 (2002) 275.
392. Van Wijk E P A. & Van Wijk R, Multi-site registration and spectral analysis of spontaneous emission from human body, Res in Complimentary Classical Natural Med, 12 (2005) 96.
393. st Century, edited by X Shen & R. Van Wijk (Kluwer, New York) 2006.
394. Van Wijk R & Van Wijk E P A, Human photon emission, Rec Res Dev Photochem Photobiol, 7 (2004) 139.
395. Van Wijk R & Van Wijk E P A, An introduction to human biophoton emission, Res Complementary Classical Natural Med, 12 (2005) 77.
396. Kobayashi M, Modern technology on physical analysis of biophoton emission and its potential extracting the physiological information, in Energy and information transfer in biological systems, edited by F Musumeci, L S Brizhik & M W Ho (World Scientific Publishers, New Jersey, London) 2003, 157.
397. Van Wijk E, Kobayashi M & Van Wijk R, Spatial characterization of human ultra-weak photon emission, in Biophotons and coherent systems in biology, biophysics and biotechnology, edited by L Beloussov, V L Voeikov & V S Martynyuk (Kluwer, New York) 2006.
398. Van Wijk R, Kobayashi M & Van Wijk E P A, Spatial characterization of human ultra-weak photon emission, J Photochem Photobiol, B 83 (2006) 69.
399. Cifra M, Van Wijk E P A, Koch H, Bosman S & Van Wijk R, Measurement of spontaneous ultra-weak photon emission from human body: spontaneous ultra-weak photon emission varies diurnally, Measurement (2007).
400. Cifra M, Van Wijk E P A, Koch H, Bosman S & Van Wijk R, Spontaneous ultra-weak photon emission from human hands is time dependent, Radioengineering, 15 (2007) 1.
401. Van Wijk E P A, Van Wijk R & Cifra M, Spontaneous ultraweak photon emission from human hands varies diurnally, in Biophotonics 2007: Optics in life science (SPIE, Bellingham) 2007, 66331J1.
402. Nakamura K & Hiramatsu M, Ultra-weak photon emission from human hand: influence of temperature and oxygen concentration on emission, J Photochem Photobiol B, 80 (2005) 156.
403. Cifra M, Measurements of spontaneous photon emission from the human body: technical aspects, parameters, time and temperature dependent fluctuations of photon emission, Ph.D. thesis, University of Zilina, Zilina, Slovenie, 2006.
404. Yang J M, Lee C, Yi S H, Yang J S & Soh K S, Biophoton emission and blood flow in human hand, ISLIS, 22 (2004) 344.
405. Orszag M, Quantum Optics (Springer Berlin) 2000, 29.
406. Bajpai R J, Quantum coherence of biophotons and living systems, Indian J.Exp Biol, 41 (2003) 514.
407. Bajpai R J, Biophotons emission in a squeezed state from a sample of Parmelia tinctorum, Phys Lett A, 322 (2004) 131.
408. Bajpai R P, Squeezed state description of the spectral decomposition of a biophoton signal, Phys Lett A, 337 (2005) 265.
409. Van Wijk R, Van Wijk E & Bajpai RP, Photon count distribution of photons emitted from three sites of a human body, J Photochem Photobiol B, 84 (2006) 46.
410. Usa M, Devaraj B, Kobayashi M, Takeda M, Ito H, Jin M & Inaba H, Detection and characterization of ultraweak biophotons from life processes, in Optical methods in biomedical and environmental sciences, edited by H Ohzu & S Komatsu (Elsevier Sciences, Amsterdam) 1994, 3.
411. Usa M & Inaba H, Spontaneous photon emission from human body, Med. Imaging Technol, 13 (1995) 47.
412. Usa M, Kobayashi M, Suzuki S, Ito H & Inaba H, ITEJ Technical Report, 15 (1991).
413. Cohen S & Popp F A, Biophoton emission of the human body, J Photochem Photobiol B, 40 (1997) 187.
414. Cohen S & Popp F A, Biophoton emission of the human body, Indian J Exp Biol, 41 (2003) 440.
415. Jung H H, Woo W M, Yang J M, Choi C, Lee J, Yoon G, Yang J S, Lee S & Soh K S, Left-right asymmetry of biophoton emission from hemiparesis patients, Indian J Exp Biol, 41 (2003) 452.
416. Berliner J, Navab M, Fogelman A, Frank J S, Dewer L L, Edwards P A, Watson A D & Lusis A J, Atherosclerosis: Basic mechanisms, Oxidation, Inflammation and Genetics, Circulation, 91 (1995) 2488.
417. Naito C, Kawamura M & Yamamoto Y, Lipid peroxides as the initiating factor of atherosclerosis, Ann N Y Acad Sci, 676 (1993) 27.
418. Scarpellini F, Sbracia M & Scarpellini L, Psychological stress and lipoperoxidation in miscarriage, Ann N Y Sci, 709 (1994) 210.
419. Adachi S, Kawamura K & Takemoto K, Oxidative damage of nuclear DNA in liver of rats exposed to psychological stress, Cancer Res, 53 (1993) 4153.
420. Schneider R H, Nidisch S I, Salerno J W, Sharma H M, Robinson C E, Nidich R J & Alexander C N, Lower lipid peroxide levels in practitioners of the Transcendental Meditation Program, Psychosom Med, 60 (1998) 38.
421. Kim D H, Moon Y S, Kim H S, Jung J S, Park H M, Suh H W, Kim Y H & Song D K, Effect of Zen Meditation on serum nitric oxide activity and lipid peroxidation. Prog Neuropsychopharmacol Biol Psychiatry, 29 (2005) 327.
422. Yadav R K, Ray R B, Vempati R & Bijlani R L, Effect of comprehensive yoga-based life style modification program on lipid peroxidation, Indian J Physiol Pharmacol, 49 (2005) 358.
423. Van Wijk E P A, Koch H, Bosman S, Van Wijk R, Spatial characterization of human ultra-weak photon emission in TM practitioners and control subjects, J Altern Complement Med, 12 (2006) 31.
424. Van Wijk E P A, Ludtke R & Van Wijk R, Differential effects of relaxation techniques on ultra-weak photon emission, J Altern Complement Med, (2008)
425. Van Wijk R, Van Wijk E P A & Bajpai R P, Quantum squeezed state analysis of spontaneous ultra-weak photon emission of practitioners of meditation and control subjects, Indian J Exp Biol, 46 (2008) 345.
426. Sato Y, Hotta N, Sakamoto N, Matsuoka S, Oshini N & Yagi K, Lipid peroxide level in plasma of diabetic patients, Biochem Med, 21 (1979) 104.
427. Murata R, Nishida T, Eto S, & Mukai N, Lipid peroxidation in diabetic rat retina, Metab Pediat Ophthalmol, 5 (1981) 83.
428. Nishigaki I, Hagihara M, Tsunekawa H, Maseki M & Yagi K, Lipid peroxide levels of serum lipoprotein fractions of diabetic patients, Biochem Med, 25 (1981) 373.
429. Stringer M D, Gorog P G, Freeman A & Kakkar V V, Lipid peroxides and atherosclerosis, Br Med J, 298 (1989) 281.
430. Van Wijk R, Wiegant F A C, Popp F A & Storms G E M G, Biophoton emission from blood serum of diabetic patients, Prog Biomedical Optics, 2328 (1994) 212.
431. Packer L, The role of anti-oxidative treatment in diabetes mellitus, Diabetologia, 36 (1993) 1212.
432. Brown M, Ross T P & Holloszy J O, Effects of ageing and exercise on soleus and extensor digitorum longus muscles of female rats, Mech Ageing Dev, 63 (1992) 69.
433. Song W, Kwak H B & Lawler J M, Effect of exercise training on iNOS and pro-apoptotic signaling in aging skeletal muscle, FASEB J, 18 (2004) A753.
434. Song W, Kwak H B & Lawler J M, Exercise training attenuates age-induced changes in apoptotic signaling in rat skeletal muscle, Antioxidants Redox Signaling, 8 (2006) 517.
435. Delp M D, Duan C, Mattson J P & Musch T I, Changes in skeletal muscle biochemistry and histology relative to fibertype in rats with heart failure, J Appl Physiol, 83 (1997) 1291.
436. Linke A, Adams V, Schulze P C, Erbs S, Gielen S, Fiehn E, Mobius-Winkler S, Schubert G & Hambrecht R, Antioxidant effects of exercise training in patients with chronic failure, Circulation, 111 (2005) 1763.
437. Song Y H, Li Y, Du J, Mitch W E, Rosenthal N & Delafontaine P, Muscle-specific expression of OGF-1 blocks angiotensin II-induced skeletal muscle waisting, J Clin Invest, 115 (2005) 451.
438. Ades P A & Coello C E, Effects of exercise and cardiac rehabilitation on cardiovascular outcomes. Med Clin North Am, 84 (2000) 251.
439. Lavie C J & Milani R V, Cardiac rehabilitation and preventive cardiology in the elderly, Cardiol Clin, 17 (1999) 233.
440. Tikkanen H O, Hamalainen E & Harkonen M, Significance of skeltal muscle properties on fitness, long-term physical training and serum lipids, Atherosclerosis, 142 (1999) 367.
441. Hammeren J, Powers S, Lawler J, Criswell D, Martin D, Lowenthal D & Pollock M, Exercise training-induced alterations in skeletal muscle oxidative and antioxidant enzyme activity in senescent rats, Int J Sports Med, 13 (1992) 412.
442. Helwig B, Schreurs K M, Haansen J, Hagerman K S, Zbrewski M G, McAllister R M, Mitchell K E & Musch T L, Training-induced changes in skeletal muscle Na+-K+ pump number and isoform expression in rats with chronic heart failure, J Appl Physiol, 94 (2003) 2225.